BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15905711)

  • 21. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG; Sandborn WJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review].
    Bjerrum JT; Munck LK; Nielsen OH
    Ugeskr Laeger; 2011 Aug; 173(35):2110-3. PubMed ID: 21884660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
    Prantera C; Bellinvia S
    Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
    Nagamata H; Torii A; Izumi M; Anami M; Yamashita N; Inadama E; Toda G
    Nihon Shokakibyo Gakkai Zasshi; 2000 Oct; 97(10):1261-6. PubMed ID: 11075590
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid.
    Haas M; Shetye KR
    Am J Kidney Dis; 2001 Jul; 38(1):205-9. PubMed ID: 11431204
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mesalazine is effective in Crohn disease 2].
    Quartarolo JP; Laegemidler F; Eskerod O
    Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mesalazine is effective in Crohn disease 1].
    Fallingborg J; Langholz E; Christensen LA; Munkholm P; Dahlerup JF
    Ugeskr Laeger; 2005 Mar; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
    [No Abstract]   [Full Text] [Related]  

  • 28. [Angioedema in Crohn's disease possibly due to mesalazine].
    Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
    Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
    [No Abstract]   [Full Text] [Related]  

  • 29. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
    Sahmoud T; Mary JY; Sahmoud T
    Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
    [No Abstract]   [Full Text] [Related]  

  • 30. Interstitial nephritis in children with Crohn's disease.
    Benador N; Grimm P; Lemire J; Griswold W; Billman G; Reznik V
    Clin Pediatr (Phila); 2000 Apr; 39(4):253-4. PubMed ID: 10791141
    [No Abstract]   [Full Text] [Related]  

  • 31. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of glomerulonephritis early in the course of Crohn's disease.
    Koçak E; Köklü S; Akbal E; Huddam B; Azak A; Yilmaz SR
    Inflamm Bowel Dis; 2010 Apr; 16(4):548-9. PubMed ID: 19637383
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mesalazine is without clinical effect in patients with Crohn disease].
    Munck LK
    Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mesalamine in the treatment of Crohn disease?].
    Nielsen OH; Thomsen OO
    Ugeskr Laeger; 2005 Apr; 167(15):1656-7. PubMed ID: 15892345
    [No Abstract]   [Full Text] [Related]  

  • 36. European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease.
    Doherty G; Katsanos KH; Burisch J; Allez M; Papamichael K; Stallmach A; Mao R; Berset IP; Gisbert JP; Sebastian S; Kierkus J; Lopetuso L; Szymanska E; Louis E
    J Crohns Colitis; 2018 Jan; 12(1):17-31. PubMed ID: 28981623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Crohn's disease at the turn of the century.
    Bickston SJ; Cominelli F
    N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
    Neĭman KP; Rumiantsev VG
    Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
    [No Abstract]   [Full Text] [Related]  

  • 39. You're the flight surgeon. Crohn's disease.
    Hartwich SA
    Aviat Space Environ Med; 2004 Aug; 75(8):716-7. PubMed ID: 15328792
    [No Abstract]   [Full Text] [Related]  

  • 40. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Hayee BH; Harris AW
    Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.